Pharmaceutical Mergers and Acquisitions: What You Need to Know
Stay informed about the latest in drug development with BioPharma Dive’s free newsletter, delivered straight to your inbox. In the […]
Stay informed about the latest in drug development with BioPharma Dive’s free newsletter, delivered straight to your inbox. In the […]
The obesity drug market is currently dominated by two major players: Eli Lilly and Novo Nordisk. Both companies are working
A report from the Make America Healthy Again (MAHA) Commission was delayed earlier this month, but leaked documents reveal plans
The US Food and Drug Administration (FDA) has given special recognition to a new experimental drug called izalontamab brengitecan (iza-bren).
Anne White, the Executive Vice President and President of Lilly Neuroscience at Eli Lilly and Company, will retire at the
In this project, ANGLE’s research team will use the Parsortix system to collect cancer cells from the blood of cancer
The US Centers for Disease Control and Prevention (CDC) reports that about one in six Americans struggles with substance use
AstraZeneca’s journey in lung cancer treatment began in 2003 with a drug called Iressa, which targeted a specific gene mutation
The International Council for Harmonisation (ICH) has opened a public consultation on its draft guidelines for managing drug impurities caused
Teva Pharmaceuticals has received FDA approval for AJOVY (fremanezumab-vfrm) as a preventive treatment for episodic migraines in children and adolescents